ERBB2 and neoplasm: The present study was consistent with other studies in that HER2/neu overexpression was mainly observed in patients <50.21,22 In the present study, HER2/neu overexpression increases with tumor grade, suggesting the higher likelihood of HER2/neu expression at higher grade tumors, thereby causing the tumors to be more invasive and more likely to relapse.